Literature DB >> 2481851

Proximal motor neuropathy, IgA paraproteinaemia and anti-myelin-associated glycoprotein reactivity.

T Hemachudha1, P Phanuphak, K Phanthumchinda, S Kasempimolporn.   

Abstract

We report a case with proximal motor neuropathy associated with benign IgA lambda paraproteinaemia. Immunoblot demonstrated reactivity to myelin-associated glycoprotein and not to P2 protein of peripheral nerve. Dramatic improvement of the polyneuropathy was observed with steroid treatment alone within 4 weeks.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2481851      PMCID： PMC2429181          DOI： 10.1136/pgmj.65.767.662

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  23 in total

1.  Prevalence of monoclonal protein in peripheral neuropathy.

Authors:  J J Kelly; R A Kyle; P C O'Brien; P J Dyck
Journal:  Neurology       Date:  1981-11       Impact factor: 9.910

2.  Osteosclerotic myeloma and peripheral neuropathy.

Authors:  J J Kelly; R A Kyle; J M Miles; P J Dyck
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

3.  Monoclonal IgM kappa antibody precipitating with chondroitin sulfate C from patients with axonal polyneuropathy and epidermolysis.

Authors:  W H Sherman; N Latov; A P Hays; M Takatsu; R Nemni; G Galassi; E F Osserman
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

4.  Immune reactions to P2 protein in human inflammatory demyelinative neuropathies.

Authors:  B Zweiman; A Rostami; R P Lisak; A R Moskovitz; D E Pleasure
Journal:  Neurology       Date:  1983-02       Impact factor: 9.910

5.  Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein.

Authors:  A J Steck; N Murray; C Meier; N Page; G Perruisseau
Journal:  Neurology       Date:  1983-01       Impact factor: 9.910

6.  Treatment of patients with neuropathy and anti-MAG IgM M-proteins.

Authors:  E Nobile-Orazio; L Baldini; S Barbieri; P Marmiroli; G Spagnol; E Francomano; G Scarlato
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

7.  Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins.

Authors:  N Latov; P E Braun; R B Gross; W H Sherman; A S Penn; L Chess
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

8.  Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein.

Authors:  C Melmed; D Frail; I Duncan; P Braun; D Danoff; M Finlayson; J Stewart
Journal:  Neurology       Date:  1983-11       Impact factor: 9.910

9.  Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia.

Authors:  W H Sherman; M R Olarte; G McKiernan; K Sweeney; N Latov; A P Hays
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

10.  Polyneuropathy with monoclonal gammopathy: studies of 11 patients.

Authors:  M C Dalakas; W K Engel
Journal:  Ann Neurol       Date:  1981-07       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.